Literature DB >> 26620441

Isotretinoin treatment of autosomal recessive congenital ichthyosis complicated by coexisting dysferlinopathy.

J Mashiah1,2, A Harel2, O Bitterman3, L Sagi4,5, A Gat5,6, Y Fellig7, S Ben-Shachar8, E Sprecher1,2,5.   

Abstract

Consanguinity is known to be associated with an increase in the prevalence of autosomal recessive disorders such as autosomal recessive congenital ichthyosis (ARCI). ARCI often responds well to retinoid treatment. We describe a patient with ARCI who improved under isotretinoin treatment. The patient subsequently developed elevated levels of serum creatinine phosphokinase (CPK), which led to the diagnosis of a second autosomal recessive disorder, dysferlinopathy, a rare myopathy characterized by muscle weakness, decreased tendon reflexes and marked elevation of CPK levels. This report demonstrates the need for physicians to remain alert to the possible coexistence of rare and mutually relevant disorders in populations with a high rate of consanguinity.
© 2015 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26620441     DOI: 10.1111/ced.12774

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Ichthyosis: case report in a Colombian man with genetic alterations in ABCA12 and HRNR genes.

Authors:  Ruben D Arias-Pérez; Salomón Gallego-Quintero; Natalia A Taborda; Jorge E Restrepo; Renato Zambrano-Cruz; William Tamayo-Agudelo; Patricia Bermúdez; Constanza Duque; Ismael Arroyave; Johanna A Tejada-Moreno; Andrés Villegas-Lanau; Alejandro Mejía-García; Wildeman Zapata; Juan C Hernandez; Gina Cuartas-Montoya
Journal:  BMC Med Genomics       Date:  2021-05-26       Impact factor: 3.063

2.  Progression to Loss of Ambulation Among Patients with Autosomal Recessive Limb-girdle Muscular Dystrophy: A Systematic Review.

Authors:  Ivana F Audhya; Antoinette Cheung; Shelagh M Szabo; Emma Flint; Conrad C Weihl; Katherine L Gooch
Journal:  J Neuromuscul Dis       Date:  2022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.